Free Writing Prospectus filed pursuant to Rule 433
Relating to the Preliminary Prospectus Supplement dated June 5, 2017 to the Prospectus dated November 22, 2016
Registration Statement No. 333-214756
AstraZeneca PLC
US$1,000,000,000 2.375% Notes due 2022
US$750,000,000 3.125% Notes due 2027
US$250,000,000 Floating Rate Notes due 2022
Final Term Sheets
| Issuer: | AstraZeneca PLC |
| Trade Date: | June 5, 2017 |
| Settlement Date: | June 12, 2017 (T+5) |
| Expected Ratings: | Moody’s: A3 (stable); S&P: A- (negative) |
US$1,000,000,000 2.375% Notes due 2022:
| Security Type: | Senior Notes |
| Aggregate Principal Amount: | $1,000,000,000 |
| Maturity Date: | June 12, 2022 |
| Coupon: | 2.375% |
| Benchmark Treasury: | 1.750% due 31 May, 2022 |
| Benchmark Treasury Spot and Yield: | 100-01, 1.743% |
| Spread to Benchmark Treasury: | 0.700% |
| Yield to Maturity: | 2.443% |
| Price to Public: | 99.682% of face amount |
| Interest Payment Dates: | June 12 and December 12, commencing December 12, 2017 |
| Gross Proceeds to Issuer: | $996,820,000 |
| Underwriting Discount and Commissions: | 0.350% of face amount |
| Net Proceeds to Issuer: | $993,320,000 |
| Redemption Provisions: | |
| Optional Make-Whole Redemption: |
At the option of the Company, from time to time, in whole or in part, as follows: (i) prior to 12 May 2022, at the redemption price equal to the greater of (A) 100% of the principal amount of the notes to be redeemed and (B) as determined by the quotation agent, the sum of the present values of the remaining scheduled payments of principal and interest on the notes to be redeemed (not including any portion of such payments of interest accrued as of the date of redemption) discounted to the date of redemption on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the treasury rate plus 0.1% and (ii) on or after 12 May 2022, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus, in each case, accrued interest thereon to but excluding the date of redemption.
|
| Optional Tax Redemption: | In the event of various tax law changes and other limited circumstances that require the Company to pay additional amounts, in whole but not in part, at a price equal to 100% of the principal amount plus accrued interest thereon to but excluding the redemption date. |
| CUSIP: | 046353 AQ1 |
| ISIN: | US046353AQ14 |
US$750,000,000 3.125% Notes due 2027:
| Security Type: | Senior Notes |
| Aggregate Principal Amount: | $750,000,000 |
| Maturity Date: | June 12, 2027 |
| Coupon: | 3.125% |
| Benchmark Treasury: | 2.375% due 15 May, 2027 |
| Benchmark Treasury Spot and Yield: | 101-22, 2.185% |
| Spread to Benchmark Treasury: | 1.000% |
| Yield to Maturity: | 3.185% |
| Price to Public: | 99.490% of face amount |
| Interest Payment Dates: | June 12 and December 12, commencing December 12, 2017 |
| Gross Proceeds to Issuer: | $746,175,000 |
| Underwriting Discount and Commissions: | 0.450% of face amount |
| Net Proceeds to Issuer: | $742,800,000 |
| Redemption Provisions: | |
| Optional Make-Whole Redemption: |
At the option of the Company, from time to time, in whole or in part, as follows: (i) prior to 12 March 2027, at the redemption price equal to the greater of (A) 100% of the principal amount of the notes to be redeemed and (B) as determined by the quotation agent, the sum of the present values of the remaining scheduled payments of principal and interest on the notes to be redeemed (not including any portion of such payments of interest accrued as of the date of redemption) discounted to the date of redemption on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the treasury rate plus 0.15% and (ii) on or after 12 March 2027, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus, in each case, accrued interest thereon to but excluding the date of redemption.
|
| Optional Tax Redemption: | In the event of various tax law changes and other limited circumstances that require the Company to pay additional amounts, in whole but not in part, at a price equal to 100% of the principal amount plus accrued interest thereon to but excluding the redemption date. |
| CUSIP: | 046353 AN8 |
| ISIN: | US046353AN82 |
US$250,000,000 Floating Rate Notes due 2022:
| Security Type: | Senior Notes |
| Aggregate Principal Amount: | $250,000,000 |
| Maturity Date: | June 10, 2022 |
| Interest Rate: | For the first interest period, LIBOR as determined on September 7, 2017 plus the Spread. Thereafter, LIBOR as determined on the applicable Interest Determination Date (as defined below) plus the Spread. |
| Spread: | 62 basis points |
| Price to Public: | 100.000% of face amount |
| Interest Payment Dates: | March 10, June 10, September 10 and December 10 of each year, commencing September 10, 2017. |
| Interest Reset Dates: | March 10, June 10, September 10 and December 10 of each year, commencing September 10, 2017. |
|
Floating Rate Interest Periods
|
From and including an Interest Reset Date to but excluding the immediately succeeding Interest Reset Date (or the Maturity Date, if earlier). |
| Interest Determination Dates | Two London business days prior to each Interest Reset Date. |
| Gross Proceeds to Issuer: | $250,000,000 |
| Underwriting Discount and Commissions: | 0.350% of face amount |
| Net Proceeds to Issuer: | $249,125,000 |
| Redemption Provisions: | |
| Optional Tax Redemption: | In the event of various tax law changes and other limited circumstances that require the Company to pay additional amounts, in whole but not in part, at a price equal to 100% of the principal amount plus accrued interest thereon to but excluding the redemption date. |
| CUSIP: | 046353 AP3 |
| ISIN: | US046353AP31 |
| Joint Book-Running Managers: |
Barclays Capital Inc. HSBC Securities (USA) Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated |
*****
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Barclays Capital Inc. at toll-free 1-888-603-5847, HSBC Securities (USA) Inc. at toll-free 1-866-811-8049, Merrill Lynch, Pierce, Fenner & Smith Incorporated at toll-free 1-800-294-1322, or Morgan Stanley & Co. LLC at toll-free 1-866-718-1649.
Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.